AK-114

N/A

Report date: 2024/11/25 20:00:28

Base Information

Drug NameAK-114
Drug Alias NameAK-114AK114
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionInterleukin-1 beta inhibitors
TargetsInterleukin-1 beta
Therapy Area/IndicationsSolid tumoursInflammationNeoplasm Metastasis +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Inactive CompaniesAkeso Pharmaceuticals Inc
Active IndicationsInflammation
Inactive IndicationsSolid tumoursNeoplasm MetastasisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A